EMD Serono

NCT00304252

Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease

NCT00303381

Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis

NCT00314288

Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

NCT00071240

Growth Hormone to Increase Immune Function in People With HIV

NCT00073541

A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer

NCT00093964

Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)

NCT00213148

Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction

NCT00111839

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

NCT00408967

Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.

NCT00430495

A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I)

NCT00595413

Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)

NCT00590824

Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma

NCT00642902

A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)

NCT00624468

Atacicept in Subjects With Optic Neuritis

NCT00813943

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status

NCT00853762

Atacicept in Multiple Sclerosis Extension Study, Phase II

NCT00957580

Trial of Pimasertib in Hematological Malignancies

NCT01040832

EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT01204840

Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)

NCT01226745

Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)

NCT01360840

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

NCT01496131

Tecemotide (L-BLP25) in Prostate Cancer

NCT01440231

Atacicept Demonstrating Dose RESponSe

NCT01693068

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

NCT01689337

A Multicenter Trial of Sprifermin (AS902330 [Recombinant Human Fibroblast Growth Factor-18]) or Placebo After Microfracture Surgery for Cartilage Injury of the Knee

NCT01782976

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

NCT01936363

Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer

NCT01963611

Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)

NCT01972568

Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus

NCT01973608

MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma

NCT02093962

Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer

NCT02070978

Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)

NCT03091374

Impact of Recombinant Human Growth Hormone on HIV Persistence

NCT03000179

Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma

NCT02968940

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

NCT03357757

Avelumab With Valproic Acid in Virus-associated Cancer

NCT03747419

Avelumab and Radiation in Muscle-Invasive Bladder Cancer

NCT03718091

M6620 (VX-970) in Selected Solid Tumors

NCT03783936

Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas

NCT03770455

Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC

NCT03737721

The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy

NCT04792073

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

NCT06031688

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

NCT06518564

Avelumab and M1774 in ARID1A-mutated Endometrial Cancer